Cardinal Health Inc (N:CAH)

May 02, 2024 06:45 am ET
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
Revenue increased 9% to $54.9 billionGAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased 20% to $2.08Fiscal year 2024 non-GAAP EPS guidance2 raised and narrowed to $7.30 to $7.40, from $7.20 to $7.35Company provides preliminary fiscal year 2025 non-GAAP EPS guidance of at least $7.50DUBLIN, Ohio, May 2, 2024  /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2024 revenues of $54.9 billion, an increase of 9% from the third quarter of fiscal year 2023.
Apr 22, 2024 06:45 am ET
Cardinal Health Reaffirms Fiscal 2024 non-GAAP EPS Guidance and Long-term Targets Amidst Nonrenewal of OptumRx Customer Contracts
DUBLIN, Ohio, April 22, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its pharmaceutical distribution contracts with OptumRx, which expire at the end of June 2024, will not be renewed. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance of $7.20 to $7.35. Despite the nonrenewal of the OptumRx contracts, the company also reiterated both its Pharmaceutical and Specialty Solutions long-term segment profit CAGR target of 4% to 6% and its consolidated non-GAAP EPS CAGR target of 12% to 14% for fiscal years 2024 to 2026, relative to a fiscal 2023 baseline.
Apr 02, 2024 08:00 am ET
Cardinal Health announces location of pharmaceutical distribution center for over-the-counter products
The Consumer Health Logistics Center will be located in Central Ohio and serve as a centralized hub for distribution of consumer health products
Mar 26, 2024 06:45 am ET
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2024 on May 2
DUBLIN, Ohio, March 26, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2024 on May 2, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Feb 06, 2024 03:35 pm ET
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2024 to shareholders of record at the close of business on April 1, 2024.
Feb 06, 2024 06:30 am ET
Cardinal Health publishes Fiscal 2023 Environmental, Social and Governance (ESG) Report
DUBLIN, Ohio, Feb. 6, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, highlighting the company's work toward building a healthier, more equitable future.
Feb 01, 2024 05:45 am ET
Cardinal Health Reports Second Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Revenue increased 12% to $57.4 billionGAAP1 operating earnings were $482 million; GAAP diluted EPS was $1.43Non-GAAP operating earnings increased 20% to $562 million; non-GAAP diluted EPS increased 38% to $1.82Fiscal 2024 non-GAAP EPS guidance raised to $7.20 to $7.35, from $6.75 to $7.002,3Fiscal 2024 non-GAAP adjusted free cash flow guidance raised to ~$2.5 billion, from ~$2.0 billionCardinal Health to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and practice enhancement organizationDUBLIN, Ohio, Feb. 1, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH)
Jan 31, 2024 05:45 am ET
Cardinal Health to acquire Specialty Networks and its PPS Analytics platform, a technology enabled multi-specialty group purchasing and practice enhancement organization in urology, rheumatology and g
Transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices Transaction creates platform for Cardinal Health expansion across specialty therapeutic areasTransaction enhances capabilities of Cardinal Health Specialty and supports ongoing build of Navista™ NetworkDUBLIN, Ohio, Jan. 31, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has entered into a definitive agreement to acquire Specialty Networks, a technology-enabled multi-specialty group purchasing and
Jan 09, 2024 05:45 am ET
Cardinal Health Announces Progress on Business and Portfolio Review and Fiscal 2024 Outlook Update
Progress achieved on company's ongoing business and portfolio review Completed review of growth businesses within the Medical Segment: investing in and further developing at-Home Solutions and OptiFreight® Logistics as part of the company's portfolio for long-term growth and value creationReview of Global Medical Products and Distribution business continues, with focus on driving operational performance through the Medical Improvement PlanReorganizing leadership structure to continue company's simplification efforts, prioritize core operational execution and drive efficiencies, accountabilit
Jan 02, 2024 05:55 am ET
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1
DUBLIN, Ohio, Jan. 2, 2024  /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Nov 14, 2023 03:10 pm ET
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Nov. 14, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.5006 per share out of the Company's capital surplus. The dividend will be payable on January 15, 2024 to shareholders of record at the close of business on January 2, 2024.
Nov 09, 2023 06:30 am ET
Cardinal Health launches SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets
SmartGown™ EDGE is the first pocketed surgical gown designed to help maintain instrument sterility and accessibility.
Nov 03, 2023 06:55 am ET
Cardinal Health Reports First Quarter Fiscal 2024 Results and Raises Fiscal 2024 Outlook
Revenue increased 10% to $54.8 billionGAAP1 operating loss was $14 million and GAAP diluted EPS was $0.02, driven by a Medical segment goodwill impairmentNon-GAAP operating earnings increased 35% to $571 million, driven by significant increases in both Pharmaceutical segment profit and Medical segment profit; non-GAAP diluted EPS increased 44% to $1.73Pharmaceutical segment profit grew 18% to $507 million and the Medical segment delivered $71 million in segment profitFiscal 2024 non-GAAP EPS guidance raised to $6.75 to $7.00, from $6.50 to $6.75DUBLIN, Ohio, Nov. 3, 2023  /PRNewswire/ -- Car
Oct 18, 2023 07:45 am ET
Cardinal Health Named to 100 Best Corporate Citizens of 2023
DUBLIN, Ohio, Oct. 18, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has been named among the 100 Best Corporate Citizens, a prestigious annual ranking by 3BL Media that assesses the environmental, social and governance (ESG) transparency and performance of the 1,000 largest public companies in the U.S.
Sep 28, 2023 08:00 am ET
Cardinal Health Launches Kangaroo OMNI™ Enteral Feeding Pump
The next generation in enteral feeding, Kangaroo OMNI™ delivers nutrition and hydration from hospital to home.
Sep 26, 2023 06:55 am ET
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2024 on November 3
DUBLIN, Ohio, Sept. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2024 on November 3, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Sep 13, 2023 09:00 am ET
Cardinal Health and Children's Hospital Association Announce Second Preventing Youth Suicide Cohort
Cardinal Health Foundation will invest $1.7M to help 14 children's hospitals nationwide prevent youth suicide.
Jul 31, 2023 09:00 am ET
Privia Health Announces Changes to Board of Directors
Privia Health Group, Inc. (Nasdaq: PRVA) today announced the election of David S. Wichmann and Pamela O. Kimmet to its Board of Directors, effective August 1, 2023. Jeff Bernstein, Managing Director of Goldman Sachs, will resign from the Board...
Jul 05, 2023 06:55 am ET
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2023 on August 15
DUBLIN, Ohio, July 5, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2023 on August 15, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Jun 26, 2023 07:00 am ET
Sotera Health Announces Jon Lyons as New Senior Vice President and Chief Financial Officer
Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced that Jon Lyons has joined the Company, effective...
Jun 15, 2023 09:00 am ET
Cardinal Health to build at-Home Solutions distribution center in South Carolina
New facility is the largest at-Home Solutions has built to date, set to accommodate continued business and home healthcare industry growth
Jun 08, 2023 06:55 am ET
Cardinal Health Investor Day to Highlight Long-Term Value Creation
Narrowing fiscal year 2023 non-GAAP diluted EPS guidance to $5.65 to $5.80, from $5.60 to $5.80 (13% growth at the mid-point)1Providing preliminary fiscal year 2024 non-GAAP diluted EPS guidance of $6.45 to $6.70 (15% growth at the mid-points)Providing long-term financial targets reflecting 12% to 14% growth of non-GAAP diluted EPS (3-year CAGR)2Raising long-term financial target for Pharmaceutical segment profit to 4% to 6% growth, from "low-single digit to mid-single digit" growthUpdating Medical Improvement Plan timeline for $650M+ in segment profit to FY263Board of Directors approved new
Jun 05, 2023 09:00 am ET
Cardinal Health announces the merger of its Outcomes™ business into Transaction Data Systems and related partnership
Cardinal Health's Outcomes™ business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions, expanding connections between payers and pharma to its nationwide pharmacy network
May 31, 2023 09:00 am ET
Cardinal Health launches Modern Commerce Solutions for Retail Independent Pharmacies powered by Square
DUBLIN, Ohio and SAN FRANCISCO, May 31, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched modern payment solutions, powered by Square, to help independent pharmacies increase operational efficiency, stay current with customer payment preferences, and access integrated software tools for their business.
May 11, 2023 07:00 am ET
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend
DUBLIN, Ohio, May 11, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved an increase to the Company's quarterly dividend, to $0.5006 per share, out of the Company's capital surplus. The dividend will be payable on July 15, 2023 to shareholders of record at the close of business on July 3, 2023.
May 10, 2023 09:00 am ET
Cardinal Health Canada to open new distribution center in Ontario
New facility to utilize state-of-the-art robotics technology to drive efficiencies and accuracy
May 04, 2023 06:55 am ET
Cardinal Health Reports Third Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance
Revenue increased 13% to $50.5 billionGAAP1 operating earnings were $572 million; GAAP diluted EPS was $1.34Non-GAAP operating earnings increased 11% to $606 million; non-GAAP diluted EPS increased 20% to $1.74Fiscal year 2023 non-GAAP EPS guidance raised and narrowed to $5.60 to $5.80, from $5.20 to $5.50Fiscal year 2023 adjusted free cash flow guidance raised and narrowed to $2.0 to $2.3 billion, from $1.5 to $2.0 billionDUBLIN, Ohio, May 4, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third quarter fiscal year 2023 revenues of $50.5 billion, an increase of 13% from the
Apr 27, 2023 07:00 am ET
Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner
Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced it has selected Cardinal Health Inc. (NYSE: CAH) to support the launch and commercialization...
Apr 19, 2023 09:15 am ET
Cardinal Health launches Stray Away™ Hair Management Drape in collaboration with MedStar Health's Institute for Innovation
DUBLIN, Ohio, April 19, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of the first-of-its-kind Stray Away™ hair management drape for more efficient surgical procedure preparation. The Stray Away™ drape is specifically designed and manufactured by Cardinal Health to help minimize hair from obstructing the surgical area and to improve patient preparation time and experience.
Apr 17, 2023 12:13 pm ET
Cardinal Health unveils two distribution centers in Central Ohio
The new facilities represent Cardinal Health's ongoing commitment to servicing customers, warehousing modernization and growing the local economy
Mar 30, 2023 06:55 am ET
Cardinal Health to Announce Third-Quarter Results for Fiscal Year 2023 on May 4
DUBLIN, Ohio, March 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2023 on May 4, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Mar 16, 2023 09:00 am ET
Swisslog's robotic fulfillment system and software to support new Cardinal Health at-Home Solutions distribution center
NEWPORT NEWS, Va., March 16, 2023 /PRNewswire/ -- Swisslog, a leading provider of best-in-class warehouse automation and software, has announced that Cardinal Health (NYSE: CAH) will install a Swisslog Automation Solution within its new at-Home Solutions distribution center in Grove City, Ohio. The facility is part of the at-Home Solutions business' multi-year strategy to increase warehouse capacity to accommodate its rapid growth.
Feb 16, 2023 09:03 am ET
RxLive and Cardinal Health’s Outcomes collaborate to enhance connectivity between providers across transitions of care
RxLive, today announced a collaboration with Outcomes, a Cardinal Health (NYSE: CAH) company, to improve data sharing and reduce communication gaps between hospitals, physicians and pharmacies. Hospital readmissions cost the U.S. healthcare...
Feb 10, 2023 03:10 pm ET
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Feb. 10, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on April 15, 2023 to shareholders of record at the close of business on April 3, 2023.
Feb 02, 2023 05:55 am ET
Cardinal Health Reports Second Quarter Fiscal Year 2023 Results and Raises Fiscal Year 2023 Non-GAAP EPS Guidance
Revenue increased 13% to $51.5 billionGAAP1 operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment; GAAP diluted loss per share was $0.50Non-GAAP operating earnings of $467 million were in-line with the second quarter of last year; non-GAAP diluted EPS increased 4% to $1.32Fiscal year 2023 non-GAAP EPS guidance raised to $5.20 to $5.50, from $5.05 to $5.40DUBLIN, Ohio, Feb. 2, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2023 revenues of $51.5 billion, an increase of 13% from
Jan 26, 2023 06:00 am ET
Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution
The platform will combine and analyze datasets for live purchasing decision support of pharmaceuticals
Jan 25, 2023 07:30 am ET
Cardinal Health releases Fiscal 2022 Environmental, Social and Governance (ESG) Report
Committed to becoming a more sustainable healthcare partner, the company makes meaningful progress in key ESG areas
Jan 03, 2023 05:55 am ET
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2023 on February 2
DUBLIN, Ohio, Jan. 3, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Dec 19, 2022 05:55 am ET
Cardinal Health Names Aaron Alt Chief Financial Officer
DUBLIN, Ohio, Dec. 19, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and will report to CEO, Jason Hollar, as a member of the company's Executive Committee effective Feb. 10.
Dec 09, 2022 08:00 am ET
New Cardinal Health research finds widespread acknowledgment of health inequities among oncologists
DUBLIN, Ohio, Dec. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) released today its latest edition of Oncology Insights, a biannual, research-based report from Cardinal Health. Featuring perspectives from nearly 200 oncologists nationwide, the 12th edition of Oncology Insights focuses on patient diversity, health equity in oncology, care management and symptom monitoring.
Nov 15, 2022 10:00 am ET
Cardinal Health brings hospital-level care to the home with new supply chain solution
Launching as a pilot with Medically Home, new technology offering will reach patients in one to two hours 
Nov 08, 2022 03:15 pm ET
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Nov. 8, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on January 15, 2023 to shareholders of record at the close of business on January 3, 2023.
Nov 04, 2022 06:55 am ET
Cardinal Health Reports First Quarter Fiscal 2023 Results
Revenue increased 13% to $49.6 billionGAAP1 operating earnings were $137 million, GAAP diluted EPS were $0.40Non-GAAP operating earnings decreased 20% to $423 million due to a decline in Medical segment profit, partially offset by an increase in Pharmaceutical segment profit; non-GAAP diluted EPS decreased 7% to $1.20Company reaffirmed fiscal year 2023 non-GAAP EPS guidanceDUBLIN, Ohio, Nov. 4, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2023 revenues of $49.6 billion, an increase of 13% from the first quarter of last year. First quarter GAAP ope
Oct 19, 2022 09:00 am ET
New Cardinal Health research highlights rheumatologists' increasing confidence in biosimilars
DUBLIN, Ohio, Oct. 19, 2022 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH) released its third edition of Rheumatology Insights, a research report based on surveys with more than 100 rheumatologists nationwide that focuses on key trends impacting one of the fastest-growing areas of specialty medicine.
Sep 27, 2022 06:55 am ET
Cardinal Health to Announce First-Quarter Results for Fiscal Year 2023 on November 4
DUBLIN, Ohio, Sept. 27, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2023 on November 4, prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Sep 15, 2022 08:00 am ET
PayrHealth Announces Collaboration with Cardinal Health
Launching a New, Robust Offering Leveraging Cardinal Health's Advanced Practice Analytics Technology Platform and PayrHealth's Payor Contracting Solution.
Sep 08, 2022 06:55 am ET
Cardinal Health Announces Pharmaceutical Segment Organizational Changes
--Victor Crawford will step down as CEO of Pharmaceutical Segment--
Sep 06, 2022 06:55 am ET
Aug 11, 2022 06:50 am ET
Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2022
Revenue increased 11% to $47.1 billion in the fourth quarterGAAP1 operating earnings were $36 million in the fourth quarter; GAAP diluted EPS were $0.50 in the fourth quarterNon-GAAP operating earnings increased 41% to $450 million in the fourth quarter; non-GAAP diluted EPS increased 36% to $1.05 in the fourth quarterGenerated operating cash flow of $3.1 billion in fiscal year 2022Company provides fiscal year 2023 guidance and reiterates long-term targetsCompany introduces Medical Improvement Plan, targeting Medical segment profit of at least $650 million by fiscal year 2025DUBLIN, Ohio, Au
Aug 11, 2022 06:45 am ET
Cardinal Health Announces Leadership Changes
-- Mike Kaufmann to Step Down as Chief Executive Officer and from Board of Directors --
Aug 01, 2022 12:00 pm ET
Cardinal Health Names Michelle Greene as Chief Information Officer
Greene previously served as SVP of EIT for the company's Pharmaceutical Segment
Jul 26, 2022 10:00 am ET
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients
RxLive, a provider of population health pharmacy solutions, today announced a $5 million Series A funding round. The digital health startup’s round was led by SpringTide, a healthtech-focused venture capital firm, with participation by Cardinal...
Jul 25, 2022 07:30 am ET
Quipt Home Medical Announces Supply Contract with Cardinal Health Further Expanding Continuum of Care
Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, is very pleased to announce the execution of a contract with Cardinal...
Jul 22, 2022 04:30 pm ET
Summary Notice to Stockholders of Cardinal Health, Inc. of Proposed Settlement of Stockholder Derivative Action, Settlement Hearing, and Right to Appear
TO:       ALL PERSONS AND ENTITIES THAT HELD CARDINAL HEALTH, INC. COMMON STOCK AS OF THE CLOSE OF TRADING ON MAY 25, 2022 AND THAT CONTINUE TO HOLD CARDINAL HEALTH COMMON STOCK AS OF THE CLOSE OF TRADING ON OCTOBER 4, 2022.
Jun 29, 2022 10:00 am ET
Cardinal Health Inventory Program Helps Reduce Delays and Shortages Ahead of Respiratory Season
DUBLIN, Ohio, June 29, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the launch of an inventory reserve program that helps labs and health systems more accurately pre-order respiratory diagnostics before the onset of seasonal flu, strep and RSV. This new program provides clearer demand signals to the supply chain ahead of the season, which helps reduce the friction felt across the healthcare landscape as the season ramps.
Jun 28, 2022 09:00 am ET
Cardinal Health, Magellan Rx Management, and Novant Health Launch On-Demand Drone Delivery with Zipline
North Carolina’s legacy of first in flight is now even richer. Three leading U.S. healthcare organizations—Novant Health, Magellan Rx Management, and Cardinal Health (NYSE: CAH)—today began long-range drone deliveries in North Carolina. Powering...
Jun 03, 2022 09:00 am ET
Cardinal Health Oncology Insights: Oncologists Report High Levels of Burnout Symptoms, Increased Stress
Research shows stress leading oncologists to consider leaving the field, retiring or selling their practice
Jun 02, 2022 09:00 am ET
Cardinal Health continues at-Home Solutions growth with new distribution center in Central Ohio
New facility to operate state-of-the-art warehouse technology, while creating new jobs 
May 10, 2022 04:15 pm ET
Cardinal Health Raises Quarterly Dividend
DUBLIN, Ohio, May 10, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4957 per share out of the Company's capital surplus. The dividend will be payable on July 15, 2022 to shareholders of record at the close of business on July 1, 2022.
May 05, 2022 06:55 am ET
Cardinal Health Reports Third Quarter Fiscal 2022 Results
Revenue increased 14% to $44.8 billionGAAP1 operating loss was $97 million due to a non-cash, pre-tax goodwill impairment of $474 million in the Medical segment; GAAP diluted loss per share was $5.05, primarily due to this impairment, net of tax effectsNon-GAAP operating earnings decreased 21% to $545 million, primarily due to a decline in Medical segment profit; Non-GAAP diluted EPS decreased 5% to $1.45Finalized the previously announced national opioid settlement agreementCompany updates FY22 guidanceDUBLIN, Ohio, May 5, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported third
May 03, 2022 07:35 am ET
Distributors Agree to Opioid Settlement With Washington State
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement with the Washington Attorney General, under which the distributors will pay up to $518 million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with Washington’s allocation under the previously announced comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities, as well as certain attorneys’ fees and costs.
Apr 27, 2022 09:00 am ET
Cardinal Health honors top clinical laboratory professionals
DUBLIN, Ohio, April 27, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced the winners and honorees of its annual Lab Excellence List, which names top clinical laboratory professionals making significant contributions to health care and patient outcomes through their research, diagnosis, innovation or advocacy. The list is part of celebrations surrounding the industry's annual Medical Laboratory Professionals Week, a more than 40-year-long tradition that celebrates lab professionals across all of health care.
Apr 01, 2022 06:55 am ET
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2022 on May 5
DUBLIN, Ohio, April 1, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2022 on May 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Mar 30, 2022 09:00 am ET
Cardinal Health expands medical distribution footprint in Ohio
DUBLIN, Ohio, March 30, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans to build a 574,670 square foot medical distribution center in the Columbus, Ohio area.
Mar 17, 2022 08:30 am ET
New Cardinal Health surgical drape helps reduce surgical site contamination risk
The incise drape is the first to feature Avery Dennison's patented BeneHold™ CHG adhesive technology 
Feb 25, 2022 06:45 am ET
Distributors Approve Opioid Settlement Agreement
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that each company has independently determined that there is sufficient participation by states and litigating political subdivisions to proceed with a comprehensive agreement to settle the vast majority of the opioid lawsuits filed by state and local governmental entities.
Feb 17, 2022 03:15 pm ET
Cue Health Taps Cardinal Health to Distribute its Pioneering Molecular COVID-19 Tests
SAN DIEGO and DUBLIN, Ohio, Feb. 17, 2022 /PRNewswire/ -- Today Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company, and Cardinal Health (NYSE: CAH) announced expanded distribution of Cue's professional use and over-the-counter COVID-19 tests.
Feb 10, 2022 03:08 pm ET
Cardinal Health named one of America's Best Large Employers 2022 by Forbes magazine
DUBLIN, Ohio, Feb. 10, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has been recognized by Forbes as one of America's Best Large Employers 2022, a list of more than 500 public and private corporations, hospitals, universities and more, across dozens of industries.   
Feb 09, 2022 08:00 am ET
Cardinal Health partners with Kinaxis to optimize digital supply chain planning
DUBLIN, Ohio, Feb. 9, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it will leverage the Kinaxis® RapidResponse® platform to increase medical product visibility and supply chain agility.
Feb 08, 2022 03:15 pm ET
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Feb. 8, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on April 15, 2022 to shareholders of record at the close of business on April 1, 2022.
Feb 07, 2022 07:00 am ET
Cardinal Health Predicts 2022 to be Turning Point for Biosimilars in the U.S.
DUBLIN, Ohio, Feb. 7, 2022 /PRNewswire/ -- Today Cardinal Health published its 2022 Biosimilars Report: The U.S. Journey and Path Ahead, a publication that brings together the latest industry data on biosimilar utilization and payer coverage with survey data from healthcare providers, and views from leading physicians and experts on biosimilars. The report delivers robust data and insights on where biosimilar adoption stands today in the U.S. and what is expected in 2022 and beyond as biosimilars come to market in key disease categories such as diabetes and immunology.
Feb 03, 2022 05:55 am ET
Cardinal Health Reports Second Quarter Fiscal 2022 Results
DUBLIN, Ohio, Feb. 3, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2022 revenues of $45.5 billion, an increase of 9% from the second quarter of last year. Second quarter GAAP operating loss was $950 million due to a non-cash, pre-tax goodwill impairment of $1.3 billion related to the Medical segment. GAAP diluted earnings per share (EPS) were $0.17, primarily due to this impairment, net of tax effects. Second quarter non-GAAP operating earnings decreased 26% to $467 million and non-GAAP diluted earnings per share (EPS) decreased 27% to $1.27, pri
Jan 31, 2022 08:30 am ET
Ember Technologies and Cardinal Health Partner to Transform the Pharmaceutical Cold Chain
LOS ANGELES, Jan. 31, 2022 /PRNewswire/ -- Ember Technologies, Inc. (Ember®) and Cardinal Health (NYSE: CAH) today announced a partnership to offer the world's first self-refrigerated, cloud-based shipping box–the Ember Cube. Ember and Cardinal Health will collaborate to deliver a cold chain solution that ensures product integrity and security throughout the supply chain, while significantly reducing shipping waste in the transport of temperature-sensitive medicines.
Jan 27, 2022 08:47 pm ET
Cardinal Health earns perfect score on Human Rights Campaign Foundation's Corporate Equality Index for the 14th consecutive year
DUBLIN, Ohio, Jan. 27, 2022 /PRNewswire/ -- Cardinal Health again has earned the perfect score of 100% on the Human Rights Campaign Foundation's Corporate Equality Index (CEI), a national benchmarking tool to measure corporate policies and practices related to LGBTQ+ (lesbian, gay, bisexual, transgender, queer and other) workplace equity. Organizations that have earned a 100% rating on the CEI have satisfied all criteria for the year and are recognized as a "Best Place to Work for LGBTQ+ Equality." This is the 14th year in a row that Cardinal Health has received a perfect score.
Jan 10, 2022 05:55 am ET
Cardinal Health Provides Medical Segment Fiscal Year 2022 Financial Update
DUBLIN, Ohio, Jan. 10, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today provided a fiscal year 2022 financial update for the Medical segment. The company now expects additional inflationary impacts and lower volumes resulting primarily from global supply chain constraints, and a lower-than-expected offset from pricing actions. The company estimates this incremental impact will be approximately $150 million to $175 million to fiscal year 2022 Medical segment profit and approximately $0.40 to $0.45 per share to non-GAAP diluted EPS.  Excluding this impact to the Medical segment and non-G
Jan 03, 2022 05:55 am ET
Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2022 on February 3
DUBLIN, Ohio, Jan. 3, 2022 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2022 on February 3 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Dec 09, 2021 07:00 am ET
Mental health distress impacting cancer patients, says new Cardinal Health survey of oncologists
DUBLIN, Ohio, Dec. 9, 2021 /PRNewswire/ -- More than 80% of oncologists frequently see mental health distress in their patients with cancer, and more than 90% say it has a significant impact on their health outcomes. These findings were released today in the latest edition of Oncology Insights, a report published by Cardinal Health Specialty Solutions based on surveys with more than 240 U.S. oncologists.
Nov 18, 2021 07:15 am ET
Cardinal Health's WaveMark™ launches supply automation solution for clinical labs
DUBLIN, Ohio, Nov. 18, 2021 /PRNewswire/ -- Cardinal Health today announced its business, WaveMark™ Supply Management and Workflow Solutions, will now be available for implementation in clinical labs across the U.S.
Nov 16, 2021 09:00 am ET
Cardinal Health Teams Up with Zipline for Automated, On-Demand Delivery to Retail Pharmacies
Cardinal Health (NYSE: CAH) and Zipline, the global leader in instant logistics, today announced a collaboration to offer on-demand autonomous aircraft delivery to pharmacies. Cardinal Health will use Zipline’s service for on-demand replenishment...
Nov 09, 2021 05:55 am ET
Cardinal Health Reports First Quarter Fiscal 2022 Results
DUBLIN, Ohio, Nov. 9, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2022 revenues of $44.0 billion, an increase of 13% from the first quarter of last year. First quarter GAAP operating earnings were $415 million and GAAP diluted earnings per share (EPS) were $0.94. Prior year first quarter GAAP results included an operating loss of $624 million due to a $1.0 billion pretax accrual related to opioid litigation. Non-GAAP operating earnings decreased 15% to $527 million in the quarter, primarily due to a decline in Medical segment profit. Non-GAAP dil
Nov 04, 2021 04:15 pm ET
Cardinal Health Board of Directors Approves Quarterly Dividend
DUBLIN, Ohio, Nov. 4, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved a quarterly dividend of $0.4908 per share. The dividend will be payable on January 15, 2022 to shareholders of record at the close of business on January 3, 2022.
Nov 04, 2021 02:58 pm ET
Biosimilars 101: A Q&A with Sonia T. Oskouei, Cardinal Health Vice President of Biosimilars
DUBLIN, Ohio, Nov. 4, 2021 /PRNewswire/ -- Biologics are the fastest growing class of drugs in the U.S.; they bring innovative, life-changing treatments to patients with cancer and chronic diseases. Due to exclusive patents, they are also very expensive and out of reach for many. When patent exclusivity ends, that opens the door for Food and Drug Administration (FDA)-approved biosimilars – which, like biologics, are medicines made from living cells (such as yeast, bacteria or animal cells) and used to prevent and treat diseases. Like generic drugs, biosimilars are expected to produce the sam
Oct 28, 2021 08:00 am ET
Cardinal Health Awarded FDA Funding to Assess Real World Evidence Results Against Clinical Trials
DUBLIN, Ohio, Oct. 28, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today it has been awarded a $750,000 contract by the U.S. Food and Drug Administration (FDA) to implement an 18-month real world evidence (RWE) study as part of the agency's efforts to advance the applicability of RWE in regulatory decision-making.
Oct 25, 2021 11:20 am ET
Cardinal Health expands solutions to mitigate missed cancer screenings
DUBLIN, Ohio, Oct. 25, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its cancer screening offerings from FUJIFILM Healthcare Americas Corporation and Polymedco that can be done either outside of a doctor's office or with less invasive procedures can help combat the increase in cancer-related deaths due to late-stage diagnoses1 from pandemic-related delays.
Oct 14, 2021 10:00 am ET
Journey Biosciences and Cardinal Health OptiFreight® Logistics Collaborate to Improve Long-Term Diabetes Care
LEBANON, N.H., Oct. 14, 2021 /PRNewswire/ -- Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications, including Diabetic Kidney Disease (DKD), today announced a collaboration with Cardinal Health (NYSE: CAH) OptiFreight® Logistics that will increase control and visibility across every transportation modality. The collaboration will deliver Journey Biosciences' critical, first-of-its-kind NaviDKD medical diagnostics screening technology to the point-of-care where innovative testing and risk evaluation t
Oct 12, 2021 07:00 am ET
Business solutions for the next public health emergency
DUBLIN, Ohio, Oct. 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today its Strategic Stock Solution now serves nearly 40 hospitals and health systems nationwide, just one year after its launch.
Oct 06, 2021 08:00 am ET
New Cardinal Health survey explores how rheumatologists are managing current industry dynamics including changing reimbursement and impacts of COVID-19
DUBLIN, Ohio, Oct. 6, 2021 /PRNewswire/ -- While demand for rheumatology care continues to grow, rheumatologists are feeling pressured by reimbursement changes, administrative duties and workforce shortages. These findings were released today in the latest edition of Rheumatology Insights, a research-based report published by Cardinal Health Specialty Solutions. Based on surveys with more than 85 U.S. rheumatologists, Rheumatology Insights focuses on key trends impacting one of the fastest-growing areas of specialty medicine.
Sep 28, 2021 01:03 pm ET
Distributors Announce Settlement With Cherokee Nation
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement with the Cherokee Nation to pay approximately $75 million over 6.5 years to resolve opioid-related claims. This settlement was negotiated in connection with ongoing negotiations toward a broad resolution of opioid-related claims brought by Native American tribes that, as previously disclosed by the companies, are not covered by the ongoing settlement process involving state and local governmental entities. The companies view today’s settlement as an important
Sep 27, 2021 04:22 pm ET
Cardinal Health Canada Announces COVID-19 Vaccination Policy to Support the Canadian Healthcare System
VAUGHAN, ON, Sept. 27, 2021 /CNW/ -- Cardinal Health Canada (NYSE: CAH) today announced an employee vaccination requirement policy as part of its ongoing efforts to safeguard employees, customers and the Canadian Healthcare system against COVID-19.
Sep 27, 2021 06:55 am ET
Cardinal Health to Webcast Discussion of First-Quarter Results for Fiscal Year 2022 on November 9
DUBLIN, Ohio, Sept. 27, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first-quarter financial results for its fiscal year 2022 on November 9 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Sep 20, 2021 09:00 am ET
Cardinal Health establishes goal to reduce Scope 1 and Scope 2 greenhouse gas emissions 50% by 2030
DUBLIN, Ohio, Sept. 20, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced it has established a goal to reduce Scope 1 and Scope 2 greenhouse gas (GHG) emissions 50% by 2030.
Aug 23, 2021 11:45 am ET
Cardinal Health Expands its DE&I Efforts with Comprehensive Talent Strategy
DUBLIN, Ohio, Aug. 23, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today a comprehensive talent strategy to increase representation of diverse employees at the manager level and above by 2030. This commitment is specifically aimed at increasing the company's global leadership representation of women, as well as African American and Black, Asian, Latinx, Indigenous and all other ethnically diverse groups in leadership roles in the U.S.
Aug 13, 2021 07:00 am ET
Cardinal Health announces redemption of outstanding notes
DUBLIN, Ohio, Aug. 13, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of all of the Company's 2.616% notes due June 2022 that are outstanding as of the early redemption date (aggregate principal amount of $572,171,000). The early redemption date is set to September 15, 2021, pursuant to the June 2, 2008 indenture and the 2.616% notes.
Aug 11, 2021 06:55 am ET
Cardinal Health Extends Pharmaceutical Distribution Agreements with CVS Health
DUBLIN, Ohio, Aug. 11, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it has extended its agreements with CVS Health to distribute pharmaceuticals to retail pharmacies and distribution centers through June 30, 2027.
Aug 10, 2021 08:00 am ET
Cardinal Health partners with Abbott and Quidel to offer rapid OTC COVID-19 tests
DUBLIN, Ohio, Aug. 10, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced its efforts to commercialize and broaden access to over-the-counter rapid COVID-19 tests through partnerships with Abbott and Quidel Corporation ("Quidel").
Aug 05, 2021 06:55 am ET
Cardinal Health reports fourth quarter and full year results for fiscal year 2021
DUBLIN, Ohio, Aug. 5, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported that fourth-quarter fiscal 2021 revenue increased 16% to $42.6 billion. This increase includes the favorable prior year comparison from reduced pharmaceutical demand related to COVID-19. Fiscal year 2021 revenues were $162.5 billion, a 6% increase from fiscal year 2020.
Aug 02, 2021 11:00 am ET
Cardinal Health completes sale of Cordis business to Hellman & Friedman
DUBLIN, Ohio, Aug. 2, 2021 /CNW/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately $1 billion includes the buyer's assumption of certain liabilities and the seller's retention of certain working capital accounts.
Aug 02, 2021 11:00 am ET
Cardinal Health completes sale of Cordis business to Hellman & Friedman
DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately $1 billion includes the buyer's assumption of certain liabilities and the seller's retention of certain working capital accounts.
Jul 21, 2021 02:15 pm ET
Distributors Announce Proposed Opioid Settlement Agreement
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have negotiated a comprehensive proposed settlement agreement which, if all conditions are satisfied, would result in the settlement of a substantial majority of opioid lawsuits filed by state and local governmental entities.
Jul 20, 2021 09:50 am ET
Thinking about trading options or stock in McKesson Corp, Cardinal Health, TAL Education Group, Cassava Sciences, or Moderna?
NEW YORK, July 20, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MCK, CAH, TAL, SAVA, and MRNA.
Jul 20, 2021 09:17 am ET
Distributors Reach Opioid Settlement Agreement With New York State
AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have agreed to pay up to $1.179 billion in a settlement with the State of New York and its participating subdivisions, including Nassau and Suffolk Counties, to resolve opioid-related claims. This settlement was negotiated in connection with the ongoing negotiations toward a broad resolution under the previously disclosed settlement framework intended to resolve claims brought by other states, counties and other political subdivisions. The companies view today’s settlement as an import
Jul 15, 2021 02:00 pm ET
Cardinal Health launches NavixRx™ Compliance Packaging and E-Commerce Storefront
DUBLIN, Ohio, July 15, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today launched two new innovative solutions – Cardinal HealthTM NavixRxTM Compliance Packaging and E-Commerce Storefront – to help independent pharmacies meet changing consumer expectations and offer personalized and convenient on-demand services.
Jun 24, 2021 06:55 am ET
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2021 on August 5
DUBLIN, Ohio, June 24, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2021 on August 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Jun 17, 2021 08:00 am ET
Outcomes™ partners with Medicaid plans to help Ohio Medicaid members get vaccinated
DUBLIN, Ohio, June 17, 2021 /PRNewswire/ -- In response to Ohio Governor Mike DeWine's request that business leaders help increase vaccination rates, four Ohio Managed Care Organizations (MCOs) are partnering with Outcomes™ to leverage the expertise and trusted status of local pharmacists for vaccine consultation and administration, particularly in underserved communities.
Jun 10, 2021 07:13 am ET
Cardinal Health™ Nuclear & Precision Health Solutions Receives U.S. Food and Drug Administration Approval for New LYMPHOSEEK® Pediatric Indication
DUBLIN, Ohio, June 10, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that LYMPHOSEEK® (technetium Tc 99m tilmanocept) injection – the first and only radiopharmaceutical agent specifically designed for targeted lymphatic mapping and guiding sentinel lymph node biopsies (SLNB) – has been approved for pediatric use by the U.S. Food and Drug Administration (FDA).
May 10, 2021 07:30 am ET
Organogenesis Appoints Jon Giacomin to Board of Directors
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today...
Mar 12, 2021 08:00 am ET
Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman
DUBLIN, Ohio, March 12, 2021 /CNW/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer's assumption of certain liabilities and seller's retention of certain working capital accounts. The transaction is expected to close in the first half of Cardinal Health's fiscal year 2022, subject to customary closing conditions and regulatory clearances.
Feb 18, 2021 07:00 am ET
Cardinal Health collaborates with HIMSS Analytics® as Certified Organization of new CISOM maturity model
DUBLIN, Ohio, Feb. 18, 2021 /PRNewswire/ -- To help health systems optimize and benchmark progress as they innovate their clinical and operational supply chains, Cardinal Health WaveMark™ Supply Management & Workflow Solutions announced a collaboration with HIMSS Analytics® as a Certified Organization of the Clinically Integrated Supply Outcomes Model (CISOM).
Feb 05, 2021 05:55 am ET
Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021
DUBLIN, Ohio, Feb. 5, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second-quarter fiscal year 2021 revenue of $41.5 billion, an increase of 5% from the second quarter of last year. Second-quarter GAAP operating earnings increased 38% to $461 million, primarily due to the beneficial comparison to the prior-year charge related to voluntary surgical gown recalls. GAAP diluted earnings per share (EPS) increased to $2.13, primarily due to the tax effect of a self-insurance loss.
Jan 05, 2021 07:00 am ET
Cardinal Health launches TotalVue™ Analytics, a logistics management tool powered by data to drive cost savings
DUBLIN, Ohio, Jan. 5, 2021 /PRNewswire/ -- OptiFreight® Logistics, a Cardinal Health (NYSE: CAH) company, announced today the launch of TotalVue™ Analytics — a tool for healthcare supply chain leaders to utilize predictive technology and data to identify logistics savings and benchmarking. Leveraging the scale of Cardinal Health, TotalVue™ Analytics provides health systems with visibility into shipping trends to identify opportunities to reduce freight costs, including inbound shipments from suppliers or outbound shipments from sites of care.
Jan 04, 2021 05:55 am ET
Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2021 on February 5
DUBLIN, Ohio, Jan. 4, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2021 on February 5 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Dec 14, 2020 03:00 pm ET
Ohio Chooses Cardinal Health for COVID-19 Vaccine Distribution
DUBLIN, Ohio, Dec. 14, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) is pleased to have been selected by the Ohio Department of Health to support its efforts to distribute COVID-19 vaccines by arranging transportation within the state of Ohio. Once a vaccine is available and Ohio receives doses for in-state distribution, Cardinal Health's OptiFreight® Logistics business will provide same-day delivery services to approximately 350 locations across 88 counties. The state of Ohio currently expects initial vaccine doses to require special handling and temperature control, and OptiFreight® Log
Dec 03, 2020 07:00 am ET
Cardinal Health Oncology Insights: Eighth Edition Explores Impact of COVID-19 on Oncologists
DUBLIN, Ohio, Dec. 3, 2020 /PRNewswire/ -- In response to the COVID-19 pandemic, U.S. oncologists have adjusted patient care by embracing telemedicine and switching more patients to oral therapies to limit office visits—but personally, more oncologists may be experiencing burnout due to the loss of face-to-face interactions with patients, according to new research from Cardinal Health Specialty Solutions.
Nov 11, 2020 01:15 pm ET
Cardinal Health Partners with CDC to Support Vaccine Access for Pharmacies
DUBLIN, Ohio, Nov. 11, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has reached an agreement with the Centers for Disease Control and Prevention (CDC) to act as a network administrator in Phase 2 of the Federal Pharmacy Partnership Strategy for COVID-19, which will enable retail independent, small chains and long-term care pharmacy customers to participate in the vaccination effort. The COVID-19 vaccine will be distributed by the CDC's central distributor.
Nov 05, 2020 05:45 am ET
Cardinal Health Reports First Quarter Fiscal 2021 Results
DUBLIN, Ohio, Nov. 5, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2021 revenues of $39.1 billion, an increase of 5% from the first quarter of last year. First quarter GAAP operating loss was $624 million due to a $1.0 billion pre-tax accrual related to opioid litigation. This quarter's accrual is incremental to the $5.6 billion accrual recorded in the first quarter of fiscal year 2020. Non-GAAP operating earnings increased 7% to $618 million in the quarter. GAAP diluted loss per share was $0.86, and non-GAAP diluted earnings per share (EPS) incre
Aug 06, 2020 06:55 am ET
Cardinal Health Reports Fourth Quarter and Full Year Results for Fiscal Year 2020
DUBLIN, Ohio, Aug. 6, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported fourth quarter fiscal year 2020 revenues of $36.7 billion, a decrease of 2 percent from the fourth quarter last year. GAAP operating earnings were $270 million and non-GAAP operating earnings were $442 million in the quarter, both of which include an estimated net negative impact of approximately $130 million due to the COVID-19 pandemic. GAAP diluted earnings per share (EPS) were $2.23, which included a pre-tax gain of $579 million related to the divestiture of a minority equity interest. Fourth quarter no
Jul 02, 2020 06:55 am ET
Cardinal Health to Webcast Discussion of Fourth-Quarter and Year-End Results for Fiscal Year 2020 on August 6
DUBLIN, Ohio, July 2, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release fourth-quarter and year-end financial results for its fiscal year 2020 on August 6 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:30 a.m. Eastern.
Jun 26, 2020 06:55 am ET
Dave Evans to join Cardinal Health Board of Directors
DUBLIN, Ohio, June 26, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its board of directors has elected David C. Evans as an independent director, effective July 1. Mr. Evans brings decades of financial expertise and strong, diverse board experiences.
May 28, 2020 07:45 am ET
Cardinal Health Oncology Insights: Oncologists Report Social Determinants of Health Play Important Role in Patient Outcomes
DUBLIN, Ohio, May 28, 2020 /PRNewswire/ -- More than 90% of oncologists said social determinants of health (SDOH) such as financial security, access to food and social isolation are significantly impacting outcomes for cancer patients, according to new research from Cardinal Health Specialty Solutions. The findings provide important insights at a time when the impact of social and economic factors on health are being examined more closely, as a result of the COVID-19 pandemic.
May 22, 2020 06:45 am ET
Cardinal Health Announces Redemption of Outstanding Notes
DUBLIN, Ohio, May 22, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that it is sending an irrevocable notice of early redemption to the holders of the Company's $500 million 4.625% notes due 2020. The early redemption date is set to June 22, 2020, pursuant to the June 2, 2008 indenture and the notes.
May 11, 2020 06:55 am ET
Cardinal Health Reports Third Quarter Results for Fiscal Year 2020
DUBLIN, Ohio, May 11, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported financial results for the third quarter of fiscal 2020 ended March 31, 2020.Third quarter revenue was $39.2 billion, an increase of 11% from the third quarter of last year.
Apr 15, 2020 06:55 am ET
Cardinal Health to Webcast Discussion of Third-Quarter Results for Fiscal Year 2020 on May 11
DUBLIN, Ohio, April 15, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2020 on May 11 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results and its outlook for the remainder of its fiscal year 2020 beginning at 8:30 a.m. Eastern.
Mar 19, 2020 06:45 am ET
Cardinal Health names Jason Hollar as new Chief Financial Officer
DUBLIN, Ohio, March 19, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its board of directors elected Jason Hollar as Chief Financial Officer, effective May 12. Mr. Hollar most recently served as the chief financial officer of Tenneco Inc., a global automotive products and services company.
Jan 23, 2020 02:25 pm ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Cardinal Health, CURO Group, Sarepta, and PG&E Corporation and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, is investigating certain officers and directors of Cardinal Health, Inc. (NYSE: CAH), CURO Group Holdings Corp. (NYSE: CURO), Sarepta Therapeutics, Inc. (NASDAQ: SRPT), and...
Jan 15, 2020 05:54 pm ET
Shareholder Alert: Robbins LLP is Investigating the Officers and Directors of Cardinal Health, Inc. (CAH)
Shareholder rights law firm Robbins LLP is investigating whether certain officers and directors of Cardinal Health, Inc. (NYSE: CAH) breached their fiduciary duties. Cardinal Health operates as an integrated healthcare services and products company.
Dec 17, 2019 07:30 am ET
Lawsuit for Investors in Cardinal Health, Inc. (CAH) announced by Shareholders Foundation
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Cardinal Health, Inc. (NYSE: CAH) shares. Investors, who purchased shares of Cardinal Health, Inc. (NYSE: CAH) in March 2015 or earlier and continue to...
Nov 07, 2019 05:50 am ET
Cardinal Health Reports First Quarter Results for Fiscal Year 2020
DUBLIN, Ohio, Nov. 7, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported first quarter fiscal year 2020 revenue of $37.3 billion, an increase of 6 percent from the first quarter last year.
Oct 16, 2019 02:59 pm ET
Shareholder Alert: Robbins Arroyo LLP Reminds Investors Cardinal Health, Inc. (CAH) Sued for Misleading Shareholders
Shareholder rights law firm Robbins Arroyo LLP reminds investors that a purchaser of Cardinal Health, Inc. (NYSE: CAH) filed a class action complaint against the company for alleged violations of the Securities Exchange Act of 1934 between March 2, 2015 and May 2, 2018. Cardinal operates as an integrated healthcare services and
Oct 08, 2019 08:00 am ET
Cardinal Health to Webcast Discussion of First Quarter Results for Fiscal Year 2020 on Nov. 7
DUBLIN, Ohio, Oct. 8, 2019 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release first quarter financial results for its fiscal year 2020 on Nov. 7 prior to the opening of trading on the New York Stock Exchange. The company will webcast a discussion of these results beginning at 8:00 a.m. Eastern.
Oct 05, 2019 10:00 am ET
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Acadia Healthcare, American Renal Associates, Camping World Holdings, and Cardinal Health and Encourages Investors to Contact t
Bragar Eagel & Squire is investigating certain officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC), American Renal Associates Holdings, Inc. (NYSE: ARA), Camping World Holdings, Inc. (NYSE: CWH), and Cardinal Health, Inc....
Sep 30, 2019 11:00 am ET
DEADLINE ALERT for CAH, PS, MDP, and GNLN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 27, 2019 11:35 pm ET
CARDINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cardinal Health, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - September 27, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (NYSE: CAH) ("Cardinal Health" or the "Company") of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Sep 27, 2019 10:50 pm ET
CARDINAL HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit Against Cardinal Health, Inc. - CAH
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of $100,000 that they have only until September 30, 2019 to file lead plaintiff applications in a securities class action lawsuit against Cardinal Health, Inc. (NYSE: CAH). Investor losses must relate to purchases of the Company’s shares between March 2, 2015 and May 2, 2018. This action is pending in the United States District Court for the Southern District of Ohio.
Sep 27, 2019 03:00 pm ET
SHAREHOLDER ALERT - Cardinal Health, Inc. (CAH) - Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Class Action and Lead Plaintiff Deadline: September 30, 2019
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cardinal Health, Inc. (“Cardinal Health” or the Company”) (NYSE: CAH) and certain of its officers, on behalf of...
Sep 27, 2019 01:19 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH
Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Sep 26, 2019 09:55 am ET
SHAREHOLDER ALERT: GTT CAH TWOU VAL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 25, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 -...
Sep 24, 2019 11:00 am ET
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cardinal Health, Inc.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 30, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE: CAH)...
Sep 24, 2019 10:40 am ET
CARDINAL HEALTH DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cardinal Health, Inc. To Contact The Firm
New York, New York--(Newsfile Corp. - September 24, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (NYSE: CAH) ("Cardinal Health" or the "Company") of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Sep 24, 2019 09:40 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of CARB, CAH, TXT and OLLI
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 23, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Sep 23, 2019 04:24 pm ET
CAH LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Reminds Cardinal Health, Inc. Investors of Important September 30th Deadline in Securities Class Action – CAH
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cardinal Health, Inc. (NYSE: CAH) from March 2, 2015 through May 2, 2018, inclusive (the “Class Period”) of the important September 30, 2019 lead plaintiff...
Sep 23, 2019 09:51 am ET
CLASS ACTION UPDATE for CAH, GVA, CVS and MDP: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Sep 20, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 -...
Sep 20, 2019 03:00 pm ET
CARB, CAH & JE - Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Sep 19, 2019 05:05 pm ET
DEADLINE ALERT for JE, CARB, VNTR, and CAH: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 19, 2019 09:30 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of CARB, CAH, TWOU and VAL
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Sep 18, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB)Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Sep 17, 2019 08:54 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH
Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Sep 17, 2019 10:02 am ET
CLASS ACTION UPDATE for MNK, CAH, GVA and SRPT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Sep 16, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB)Class Period: 2/7/2019 -...
Sep 16, 2019 12:15 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cardinal Health, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE:CAH) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities...
Sep 16, 2019 09:20 am ET
SHAREHOLDER ALERT: GNLN CAH CURLF PS: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 13, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Sep 13, 2019 03:00 pm ET
Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Deadlines
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Sep 12, 2019 09:22 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of MMM, CARB, CAH and TWOU
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 11, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 -...
Sep 11, 2019 03:41 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cardinal Health, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE:CAH) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities...
Sep 10, 2019 09:31 am ET
CLASS ACTION UPDATE for NGHC, GTT, CAH and TXT: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Sep 09, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Sep 06, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 -...
Sep 06, 2019 06:00 pm ET
ROSEN, A LEADING LAW FIRM, Reminds Cardinal Health, Inc. Investors of Important September 30th Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the F
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cardinal Health, Inc. (NYSE: CAH) from March 2, 2015 through May 2, 2018, inclusive (the “Class Period”) of the important September 30, 2019 lead plaintiff...
Sep 06, 2019 03:00 pm ET
Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) Class Actions - Bronstein, Gewirtz & Grossman, LLC
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Sep 06, 2019 09:27 am ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of KPTI, EGBN, MNK and CAH
The securities litigation law firm of Kuznicki Law PLLC issues the following notice on behalf of shareholders of the following publicly traded companies. Shareholders who purchased shares in these companies during the dates listed below are...
Sep 05, 2019 03:49 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH
Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Sep 05, 2019 10:15 am ET
SHAREHOLDER ALERT: MMM CTST GTT CAH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 04, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Sep 04, 2019 02:30 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors who Suffered Losses Exceeding $100,000 in Cardinal Health, Inc. to Contact the Firm
New York, New York--(Newsfile Corp. - September 4, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (NYSE: CAH) ("Cardinal Health" or the "Company") of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Sep 04, 2019 09:33 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of INS, OMCL, KPTI and CAH
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Sep 03, 2019 09:31 am ET
CLASS ACTION UPDATE for MMM, LB, CAH and PS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Sep 02, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 -...
Sep 01, 2019 07:38 am ET
SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Cardinal Health, Inc. – CAH
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Cardinal Health, Inc. (NYSE: CAH) from March 2, 2015 through May 2, 2018, inclusive (the “Class Period”). The lawsuit seeks to...
Aug 30, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:Carbonite, Inc. (CARB) Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Aug 30, 2019 06:00 pm ET
LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm
SAN DIEGO, Aug. 30, 2019 /PRNewswire/ -- Johnson Fistel, LLP announces that class action lawsuits have been commenced on behalf of shareholders of the publicly-traded companies listed below. The Private Securities Litigation Reform Act of 1995 permits any investor who purchased a common stock during the Class Period to seek appointment as lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation.  The lead plaintiff can select a law firm of its choice.  An investor's ability to share in any potential future recovery is not dependent upon serving a
Aug 30, 2019 03:02 pm ET
ROSEN, A HIGHLY RANKED LAW FIRM, Reminds Cardinal Health, Inc. Investors of Important September 30th Deadline in Securities Class Action – CAH
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cardinal Health, Inc. (NYSE: CAH) from March 2, 2015 through May 2, 2018, inclusive (the “Class Period”) of the important September 30, 2019 lead plaintiff...
Aug 30, 2019 03:00 pm ET
Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) - Bronstein, Gewirtz & Grossman, LLC – Class Action Update
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Aug 29, 2019 11:27 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cardinal Health, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE:CAH) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities...
Aug 29, 2019 01:51 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH
Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Aug 28, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 -...
Aug 27, 2019 10:03 am ET
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FRED, CAH, ABMD and CVS
The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 26, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Aug 24, 2019 10:22 am ET
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In ABMD, CARB, CAH or VNTR To Contact The Firm
New York, New York--(Newsfile Corp. - August 24, 2019) - Faruqi & Faruqi, LLP, a leading national securities law firm, encourages investors in the following companies to contact the firm:
Aug 24, 2019 10:15 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH
NEW YORK, Aug. 24, 2019 /CNW/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. ("Cardinal Health" or the "Company") (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
Aug 24, 2019 10:15 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH
NEW YORK, Aug. 24, 2019 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. ("Cardinal Health" or the "Company") (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
Aug 23, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB)Class Period: 2/7/2019 -...
Aug 23, 2019 03:00 pm ET
Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) – Class Action - Bronstein, Gewirtz & Grossman, LLC
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Aug 22, 2019 09:45 am ET
CLASS ACTION UPDATE for RBGLY, NFLX, JE and CAH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Aug 21, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 - 7/25/2019Lead Plaintiff Motion Deadline: September 30,...
Aug 20, 2019 04:47 pm ET
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Cardinal Health, Inc. To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE:CAH) of the September 30, 2019 deadline to seek the role of lead plaintiff in a federal securities...
Aug 20, 2019 04:05 pm ET
Cardinal Health, Inc. Investor Alert: Class Action Lawsuit Filed Against CAH
BOSTON, Aug. 20, 2019 /PRNewswire/ -- Thornton Law Firm LLP announces that a lawsuit has been filed on behalf of shareholders of Cardinal Health, Inc. (NYSE ticker: CAH). Investors who purchased CAH securities between March 2, 2015 and May 2, 2018, and are interested in learning about the case or serving as a lead plaintiff, are encouraged to visit www.tenlaw.com/cases/Cardinal to submit your information and learn more about the case. The lawsuit alleges that Cardinal Health violated the federal securities laws.
Aug 20, 2019 03:58 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. – CAH
Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Aug 20, 2019 02:00 pm ET
CAH LOSS NOTICE: ROSEN, A LEADING LAW FIRM, Reminds Cardinal Health, Inc. Investors of Important September 30th Deadline in Securities Class Action – CAH
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cardinal Health, Inc. (NYSE: CAH) from March 2, 2015 through May 2, 2018, inclusive (the “Class Period”) of the important September 30, 2019 lead plaintiff...
Aug 20, 2019 09:21 am ET
SHAREHOLDER ALERT: TEVA EGBN CAH EVH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead...
Aug 19, 2019 10:50 pm ET
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits: Carbonite, Inc. (CARB) Class Period: 2/7/2019 -...
Aug 16, 2019 10:50 pm ET
SHAREHOLDER ALERT: CLAIMSFILER REMINDS CAH, CARB, MMM, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits: 3M Company (MMM) Class Period: 2/9/2017 - 5/28/2019Lead Plaintiff Motion Deadline: September 27,...
Aug 16, 2019 03:43 pm ET
CLASS ACTION UPDATE for EQT, CAH and CVS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the...
Aug 16, 2019 03:00 pm ET
Carbonite, Inc. (CARB), Cardinal Health, Inc. (CAH) & Just Energy Group Inc. (JE) – Class Action - Bronstein, Gewirtz & Grossman, LLC
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Aug 15, 2019 06:05 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cardinal Health, Inc. - CAH
Pomerantz LLP is investigating claims on behalf of investors of Cardinal Health, Inc. (“Cardinal Health” or the “Company”) (NYSE: CAH). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext....
Aug 15, 2019 06:00 pm ET
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds Cardinal Health, Inc. Investors of Important Deadline in Securities Class Action – CAH
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cardinal Health, Inc. (NYSE: CAH) from March 2, 2015 through May 2, 2018, inclusive (the “Class Period”) of the important September 30, 2019 lead plaintiff deadline in the case. The lawsuit seeks to recover damages for Cardinal Health investors under the federal securities laws.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.